Trade NUVB anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Nuvation Bio Inc. (NUVB) is trading at US$6.77, down 2.31% today as of Sep 3, 16:00 EDT. The company has a market capitalisation of US$2.43B. Over the past 52 weeks, NUVB has traded between US$2.99 and US$9.75. On Syfe you can trade NUVB with $0 commission and add it to your watchlist.
| Previous close | US$6.93 |
|---|---|
| Market cap | US$2.43B |
| 52-week range | US$2.99 – US$9.75 |
| Volume | 5.26M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Nuvation Bio Inc.
Nuvation Bio, Inc. is a biopharmaceutical company tackling some of the unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. The company was founded by David Hung on March 20, 2018 and is headquartered in New York, NY.
Year: 2021
Nuvation Bio Inc. (NUVB) stock is trading at US$6.77, -2.31% from the previous close of US$6.93.
The market cap for Nuvation Bio Inc. (NUVB) stock is approximately US$2.43B.
The 52-week high for Nuvation Bio Inc. (NUVB) stock is US$9.75.
The 52-week low for Nuvation Bio Inc. (NUVB) stock is US$2.99.
Nuvation Bio Inc. (NUVB) does not currently pay a dividend.
Stay on top of NUVB
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
